DeepMed Research

Tongji University Tongji Hospital of(Formerly Ganquan Hospital)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI

Not Applicable

Recruiting

Conditions: Remimazolam
Awake Endotracheal Intubation

Interventions: Drug: Dos of Afentanil 50
Drug: Dos of Afentanil 40
Drug: Dos of Afentanil 30
Drug: Dos of Afentanil 20
Drug: Dos of Afentanil 60
Drug: Dos of Afentanil 70
Drug: Dos of Afentanil 80
Drug: Dos of Afentanil 90
Drug: Dos of Afentanil 100

First Posted Date: 2023-09-07

Last Posted Date: 2023-09-07

Lead Sponsor: Tongji Hospital

Target Recruit Count: 180

Registration Number: NCT06026566

Locations: 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan, Hubei, China

Development and Validation of a Nomogram Predicting the Probability of in Hirschsprung Children Following Surgery

Completed

Conditions: Develop a Nomogram

Interventions: Other: training set

First Posted Date: 2023-09-06

Last Posted Date: 2023-09-06

Lead Sponsor: Tongji Hospital

Target Recruit Count: 600

Registration Number: NCT06025188

Locations: 🇨🇳
Tongji hospital affiliated to tongji medical college of huazhong university of science and technology, Wuhan, Hubei, China

A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients

Active, not recruiting

Conditions: Tuberculosis

First Posted Date: 2023-09-01

Last Posted Date: 2023-09-01

Lead Sponsor: Tongji Hospital

Target Recruit Count: 900

Registration Number: NCT06021041

Locations: 🇨🇳
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
🇨🇳
Wuhan Pulmonary Hospital(Wuhan Institute for Tuberculosis Control), Hubei, Wuhan, China

A Retrospective Cohort Study of HFRS

Recruiting

Conditions: HFRS

First Posted Date: 2023-08-31

Last Posted Date: 2023-08-31

Lead Sponsor: Tongji Hospital

Target Recruit Count: 500

Registration Number: NCT06020326

Locations: 🇨🇳
No.1 Peoples Hospital of Guangshui, Guangshui, Hu Bei Province, China
🇨🇳
Huanggang Central Hospital, Huanggang, Hu Bei Province, China
🇨🇳
People's Hospital of Luotian County, Huanggang, Hu Bei Province, China

and more 5 locations

A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System Tuberculosis

Completed

Conditions: Central Nervous System Tuberculosis

First Posted Date: 2023-08-25

Last Posted Date: 2023-08-28

Lead Sponsor: Tongji Hospital

Target Recruit Count: 638

Registration Number: NCT06011915

Locations: 🇨🇳
Wuhan Pulmonary Hospital(Wuhan Institute for Tuberculosis Control), Hubei, Wuhan, China
🇨🇳
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

A 6-month Follow-up Study of Patients With Severe Fever With Thrombocytopenia Syndrome

Recruiting

Conditions: Severe Fever With Thrombocytopenia Syndrome

First Posted Date: 2023-08-25

Last Posted Date: 2023-08-25

Lead Sponsor: Tongji Hospital

Target Recruit Count: 1500

Registration Number: NCT06011902

Locations: 🇨🇳
NO.1 Peoples Hospital of Guangshui, Guangshui, Hubei, China
🇨🇳
People's Hospital Of Luotian County, Huanggang, Hubei, China
🇨🇳
Huanggang Central Hospital, Huanggang, Hubei, China

and more 5 locations

Safety and Efficacy of Low-intensity Laser Therapy in the Treatment of Chronic Musculoskeletal Pain

Not Applicable

Not yet recruiting

Conditions: Pain, Chronic

Interventions: Drug: Non-steroidal drug (Celecoxib) group
Device: Low intensity laser treatment

First Posted Date: 2023-08-24

Last Posted Date: 2023-08-24

Lead Sponsor: Tongji Hospital

Target Recruit Count: 860

Registration Number: NCT06009900

Locations: 🇨🇳
China Resources & WISCO General Hospital, Wuhan, Hubei, China
🇨🇳
LinFen People's Hospital, Linfen, Shanxi, China
🇨🇳
Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China

and more 2 locations

Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study

Phase 4

Recruiting

Conditions: HFRS (Hemorrhagic Fever With Renal Syndrome)

Interventions: Drug: IVIG 20g/d
Drug: IVIG 10g/d

First Posted Date: 2023-08-24

Last Posted Date: 2023-08-24

Lead Sponsor: Tongji Hospital

Target Recruit Count: 100

Registration Number: NCT06009042

Locations: 🇨🇳
People's Hospital of Macheng City, Affiliated Hospital of Hubei University of Science and Technology, Macheng, Hu Bei Province, China
🇨🇳
No.1 Peoples Hospital of Guangshui, Guangshui, Hu Bei Province, China
🇨🇳
Huanggang Central Hospital, Huanggang, Hu Bei Province, China

and more 6 locations

The Dose Range of Remimazolam Besylate in Different Age Groups

Not Applicable

Recruiting

Conditions: Remimazolam
Anesthesia

Interventions: Drug: Remimazolam besylate
Drug: Propofol

First Posted Date: 2023-08-24

Last Posted Date: 2023-09-06

Lead Sponsor: Tongji Hospital

Target Recruit Count: 1876

Registration Number: NCT06009991

Locations: 🇨🇳
ongji Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan, Hubei, China

Long-term Follow-up Study of COVID-19

Recruiting

Conditions: COVID-19

First Posted Date: 2023-08-14

Last Posted Date: 2023-08-14

Lead Sponsor: Tongji Hospital

Target Recruit Count: 5700

Registration Number: NCT05986435

Locations: 🇨🇳
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan, Hu Bei Province, China
🇨🇳
Wuhan Seventh Hospital, Wuhan, Hu Bei Province, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy